Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2006-07-12

FDA Approved: PULMICORT FLEXHALER — Original Application (H2-Pharma LLC)

View source ↗

Summary

FDA approved Pulmicort Flexhaler (budesonide) through an Original Application (NDA021949) by H2-Pharma LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PULMICORT FLEXHALER (BUDESONIDE)

Snippet

ORIG AP for PULMICORT FLEXHALER (BUDESONIDE)